1.214EURMkt Cap: 16.55M EURP/E: —Last update: 2026-05-21
Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company is developing signaling-speci…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap16.55M EUR
Enterprise Value14.40M EUR
Revenue (TTM)2.08M EUR
Gross Profit2.08M EUR
Net Income (TTM)-6.43M EUR
Revenue/Share0.1520 EUR
Last Price1.214 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees16
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0014007ZB4
Valuation
P/E (Trailing)—
P/E (Forward)7.14
PEG—
EV/EBITDA-2.36
EV/Revenue6.91
P/S7.94
P/B3.72
EPS (TTM)-0.47
EPS (Forward)0.17
52W Range
1.18443% of range1.254
52W High1.254 EUR
52W Low1.184 EUR
Profitability
Gross Margin100.00%
Oper. Margin-172.75%
EBITDA Margin-293.14%
Profit Margin0.00%
ROE-144.94%
ROA-53.40%
Growth
Revenue Growth-17.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.35M EUR
CapEx (TTM)4.00K EUR
FCF Margin-148.83%
FCF Yield-18.74%
Net Debt-2.10M EUR
Net Debt/EBITDA0.34
Balance Sheet
Debt/Equity1.49
Current Ratio4.40
Quick Ratio4.13
Book Value/Sh0.3260 EUR
Cash/Share0.6400 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.63M
Float3.89M
Insiders36.44%
Institutions27.52%
Technical
SMA 501.288 (-5.7%)
SMA 2001.237 (-1.9%)
Beta0.59
S&P 52W Chg27.23%
Avg Vol (30d)22.05K
Avg Vol (10d)21.58K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—